Trials / Completed
CompletedNCT06812416
Effectiveness of Qualia NAD+ Supplementation on NAD Levels
Effectiveness of Qualia NAD+ Supplementation on Intracellular NAD Levels: a Randomized Double-Blind Parallel Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 92 (actual)
- Sponsor
- Qualia Life Sciences · Industry
- Sex
- All
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The current study is designed as a randomized double-blind placebo-controlled parallel trial. It aims to investigate the efficacy of Qualia NAD+ on intracellular NAD levels in blood samples (primary outcomes) and health-related quality of life (secondary outcomes) in an adult population experiencing moderate to severe joint pain between ages of 40 and 65 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Qualia NAD+ | Qualia NAD+ |
| DIETARY_SUPPLEMENT | Rice Flour Placebo | Rice Flour Placebo |
Timeline
- Start date
- 2023-10-24
- Primary completion
- 2024-03-11
- Completion
- 2024-03-11
- First posted
- 2025-02-06
- Last updated
- 2025-02-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06812416. Inclusion in this directory is not an endorsement.